Garlic studies
This article was originally published in The Tan Sheet
Executive Summary
Although garlic leads to moderate cholesterol reduction in studies lasting from one to three months, long-term trials do not demonstrate a significant effect compared to placebo, according to an Agency for Healthcare Research & Quality analysis of 36 randomized trials. AHRQ is expected to release an executive summary of the report the week of Oct. 2 that notes garlic may help prevent heart attacks by reducing clotting, but also calling for additional research
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning